Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Multiple myeloma (MM) is a plasma cell neoplasm associated with a broad variety of genetic lesions. In spite of this genetic heterogeneity, MMs share a characteristic malignant phenotype whose underlying molecular basis remains poorly characterized. In the present study, we examined plasma cells from MM using a multi-epigenomics approach and demonstrated that, when compared to normal B cells, malignant plasma cells showed an extensive activation of regulatory elements, in part affecting coregulated adjacent genes. Among target genes up-regulated by this process, we found members of the NOTCH, NF-kB, MTOR signaling, and TP53 signaling pathways. Other activated genes included sets involved in osteoblast differentiation and response to oxidative stress, all of which have been shown to be associated with the MM phenotype and clinical behavior. We functionally characterized MM-specific active distant enhancers controlling the expression of thioredoxin (TXN), a major regulator of cellular redox status and, in addition, identified PRDM5 as a novel essential gene for MM. Collectively, our data indicate that aberrant chromatin activation is a unifying feature underlying the malignant plasma cell phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Charting a dynamic DNA methylation landscape of the human genome
Ziller, M. J., Gu, H., Müller, F., Donaghey, J., Tsai, L. T.-Y., Kohlbacher, O., De Jager, P. L., Rosen, E. D., Bennett, D. A., Bernstein, B. E., et al. (2013) · Nature · doi:10.1038/nature12433 · Cited by 1,357 · cited 1×
“As binding of TFs is associated with local DNA demethylation (Kulis et al. 2013; Ziller et al. 2013; Sardina et al. 2018), we studied the methylation levels of CpGs located within or close to the enriched TF binding motifs.”
Insulator dysfunction and oncogene activation in IDH mutant gliomas
Flavahan, W. A., Drier, Y., Liau, B. B., Gillespie, S. M., Venteicher, A. S., Stemmer-Rachamimov, A. O., Suvà, M. L., & Bernstein, B. E. (2016) · Nature · doi:10.1038/nature16490 · Cited by 1,288
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226
Intragenic DNA methylation prevents spurious transcription initiation
Neri, F., Rapelli, S., Krepelova, A., Incarnato, D., Parlato, C., Basile, G., Maldotti, M., Anselmi, F., & Oliviero, S. (2017) · Nature · doi:10.1038/nature21373 · Cited by 739 · cited 7×
“high DNAmethylation in elongating gene bodies has been associated with recruitment of DNA methyltransferases DNMT3A/B by H3K36me3 (Neri et al. 2017; Teissandier and Bourc’his 2017).”
InfluentialIRF4 addiction in multiple myeloma
Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature · doi:10.1038/nature07064 · Cited by 730 · cited 6×
“publications indicating that IRF4 or FOXM1 inhibition induces cell death and influences the proliferation in MM cell lines, although efficient strategies to block these TFs in MM patients are still missing (Shaffer et al. 2008;Morelli et al. 2015; Gu et al. 2016).”
InfluentialThe thioredoxin system in cancer
Arnér, E. S. J., & Holmgren, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.009 · Cited by 589 · cited 4×
“One of the major systemsmaintaining cellular redox homeostasis is the thioredoxin system (Arnér and Holmgren 2006).”
InfluentialEpigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions
Zentner, G. E., Tesar, P. J., & Scacheri, P. C. (2011) · Genome Research · doi:10.1101/gr.122382.111 · Cited by 564
Cited by
Carrasco-Leon, A., Ezponda, T., Meydan, C., Valcárcel, L. V., Ordoñez, R., Kulis, M., Garate, L., Miranda, E., Segura, V., Guruceaga, E., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01147-y · Cited by 50
“lncRNAs in MM was epigenetically regulated, ChIP-seq data of six histone marks from our previous work [21], defining common chromatin states, were analyzed (H3K4me3, H3K4me1, H3K27ac, H3K36me3, H3K27me3, and H3K9me3) [23].”
BackgroundMethodSelf-citationValcárcel, L. V., Amundarain, A., Kulis, M., Charalampopoulou, S., Melnick, A., San Miguel, J., Martín-Subero, J. I., Planes, F. J., Agirre, X., & Prosper, F. (2021) · Leukemia · doi:10.1038/s41375-021-01263-9 · Cited by 17
Self-citationAng, D. A., Carter, J.-M., Deka, K., Tan, J. H. L., Zhou, J., Chen, Q., Chng, W. J., Harmston, N., & Li, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-46728-4 · Cited by 13
“Written, informed consent and ethical approval by the National Healthcare Group Domain Speci fi c Review Board (NHG DSRB: 2007/00173) was obtained for human samples, in accordance with the Declaration of Helsinki.”
Metadata
- Authors
- Ordoñez, R., Kulis, M., Russiñol, N., Chapaprieta, V., Carrasco-Leon, A., García-Torre, B., Charalampopoulou, S., Clot, G., Beekman, R., Meydan, C., Duran-Ferrer, M., Verdaguer-Dot, N., Vilarrasa-Blasi, R., Soler-Vila, P., Garate, L., Miranda, E., San José-Enériz, E., Rodriguez-Madoz, J. R., Ezponda, T., Martínez-Turrilas, R., Vilas-Zornoza, A., Lara-Astiaso, D., Dupéré-Richer, D., Martens, J. H. A., El-Omri, H., Taha, R. Y., Calasanz, M. J., Paiva, B., San Miguel, J., Flicek, P., Gut, I., Melnick, A., Mitsiades, C. S., Licht, J. D., Campo, E., Stunnenberg, H. G., Agirre, X., Prosper, F., & Martin-Subero, J. I.
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2020-08-20
- Volume
- 30
- Issue
- 9
- Pages
- 1217-1227
- ISSN
- 1088-9051 (ISSN-L)
- 1549-5469
- OpenAlex
- W3080778103
- Cited by
- 55
- References
- 18
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma. https://app.cochat.ai/papers/10.1101/gr.265520.120
- The paper
- Ordoñez, R., Kulis, M., Russiñol, N., Chapaprieta, V., Carrasco-Leon, A., García-Torre, B., Charalampopoulou, S., Clot, G., Beekman, R., Meydan, C., Duran-Ferrer, M., Verdaguer-Dot, N., Vilarrasa-Blasi, R., Soler-Vila, P., Garate, L., Miranda, E., San José-Enériz, E., Rodriguez-Madoz, J. R., Ezponda, T., . . . Martin-Subero, J. I. (2020). Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma. Genome Research. https://doi.org/10.1101/gr.265520.120
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.